Anderson gets my vote for the honor of least trustworthy drug/biotech analyst on Wall Street.
I have Pantingis and Ashoff as mine.
I don't recall a single biotech call either one of these guys has gotten correct (unless you consider their pre-market after-the-fact upgrades/downgrades (reversing their prior ratings) as legit).
But, I will make note of your pick for future stocks I am looking at. lol.